Skip to main content
. Author manuscript; available in PMC: 2023 May 4.
Published in final edited form as: Cancer Immunol Res. 2023 May 3;11(5):629–645. doi: 10.1158/2326-6066.CIR-22-0655

Table 1.

Immune composition of normal brain and EGFR glioblastomas.

Percent of CD45+ cells ± SEM P values
Normal Brain EGFR WT EGFR vIII WT vs Normal vIII vs Normal WT vs vIII
CD8+ T cells 4.12 ± 1.35 27.03 ± 3.68 27.29 ± 1.5 0.0025 <0.0001 n.s.
CD4+ T cells 1.12 ± 0.59 7.63 ± 1.5 2.21 ± 0.43 0.0214 n.s. 0.0042
Regulatory T cells n.d. 4.78 ± 1.69 0.00021 ± 0.0001 n.d. n.d. 0.0159
PMN-MDSCs 0.33 ± 0.15 5.46 ± 1.01 14.33 ± 1.51 0.0088 <0.0001 0.0001
M-MDSCs 4.91 ± 2.44 17.02 ± 2.72 16.46 ± 3.04 0.0228 0.0387 n.s.
BMDMs 4.79 ± 2.44 28.3 ± 4.14 24.3 ± 2.69 0.005 0.001 n.s.
Microglia 84.72 ± 5.03 9.76 ± 2.33 15.41 ± 1.03 <0.0001 <0.0001 0.0477

Flow cytometry analysis of intratumoral CD45+ cells for the indicated cell type (percent). Data is Mean±SEM of biological replicates, p values from unpaired t test, two-tailed. ns, not significant.